BMS was one of the first companies to state that it would not enforce its patents on antiretrovirals in sub-Saharan Africa. Since 2001, the company has entered into twelve immunity-from-suit agreements for their antiretrovirals Videx® (didanosine) and Zerit® (stavudine). In addition, BMS has entered into two Technology Transfer and Licensing agreements and two Immunity From Suit agreements covering their antiretroviral Reyataz® (atazanavir).
In 2013, Bristol-Myers Squibb entered into an agreement with the Medicines Patent Pool which aims to further access to atazanavir in developing world countries. This agreement includes 110 least developed, low- and middle- income countries where approximately 29 million people are living with HIV. There is no fixed limit on the number of sublicensees, instead, the aim of this agreement is to create a supply of licensed product that can sustainably meet the demands for atazanavir in the territory, including pediatric formulations. A key feature of the agreement is that there are no royalties for countries that were part of the legacy agreements or for sublicensee sales of pediatric formulations in any of the 110 countries included in the Territory.
In 2006, BMS granted a royalty-free license to two generics companies, Aspen (Africa) and Emcure (India), to sell atazanavir in sub-Saharan Africa and India. BMS also transferred technical know-how related to the manufacturing, testing, packaging, storage and handling of the active pharmaceutical ingredient and finished dosage form of atazanavir to these two generic companies. Also in 2006, BMS agreed to allow generic companies seeking approval of generic combination products (including one or more of BMS’ antiretroviral medicines) for developing countries, under the U.S. PEPFAR program, access to confidential regulatory information as long as these companies were operating under appropriate laws and regulations.
|Location||Eastern Europe, West Africa, Southern Africa, South Asia, North Africa and Middle East, Latin America and Caribbean, Eastern Africa, East Asia and Pacific, Central Asia, Central Africa|